Don’t Forget, National Prescription Drug Take-Back Day Is This Month!

TOP Web Exclusives - Online Only, Practical Issues for Pharmacists

The 10th National Prescription Drug Take-Back Day is taking place on Saturday, September 26 from 10 am to 2 pm local time in every state. If you live in Pennsylvania or Delaware, the event will be taking place at that time Saturday September 12. The sites will be set up throughout communities nationwide so that local residents can return their unwanted, unneeded, or expired prescription drugs for safe disposal. The past 9 take-back events led to the collection of 2411 tons of drugs.

The National Prescription Drug Take-Back addresses a vital public safety and public health issue. Many patients are not aware that the medicines in their cabinets are highly susceptible to diversion, misuse, and abuse. Rates of prescription drug abuse in the United States are at alarming levels, as are the number of accidental poisonings and overdoses caused by these drugs. Studies show that many abused prescription drugs are obtained from family and friends, including from the home medicine cabinet. In addition, many Americans do not know how to properly dispose of their unused medicine, often flushing them down the toilet or throwing them in the garbage—both potential safety and health hazards.

This National Prescription Drug Take-Back event is a great opportunity to educate your patients about prescription drugs and their safe disposal. For more information about collection sites, visit the US Drug Enforcement Administration website.

US Drug Enforcement Administration. DEA announces 10th national prescription drug take-back. www.dea.gov/divisions/hq/2015/hq072815.shtml. Published July 28, 2015. Accessed August 26, 2015.

Related Items
Actemra First FDA-Approved Treatment for CAR T-Cell–Induced Severe Cytokine Release Syndrome
JHOP Web Exclusives published on October 30, 2017 in FDA News & Updates, Online Only
Mylotarg Now Approved for the Treatment of Patients with CD33-Positive AML
JHOP Web Exclusives published on October 30, 2017 in FDA News & Updates, Online Only
Nivolumab Receives New Indication for dMMR and MSI-H Metastatic Colorectal Cancer
JHOP Web Exclusives published on October 30, 2017 in FDA News & Updates, Online Only
Besponsa a New Treatment Option for Patients with Relapsed/Refractory B-Cell ALL
JHOP Web Exclusives published on October 9, 2017 in FDA News & Updates, Online Only
Kymriah First Gene Therapy Approved by the FDA, Indicated for Young Patients with B-Cell ALL and CD19
JHOP Web Exclusives published on October 9, 2017 in FDA News & Updates, Online Only
FDA News - September 2017
JHOP Web Exclusives published on September 8, 2017 in FDA News & Updates, Online Only
FDA News - August 2017
JHOP Web Exclusives published on August 1, 2017 in FDA News & Updates, Online Only
FDA News - June 2017
JHOP Web Exclusives published on June 1, 2017 in FDA News & Updates, Online Only
FDA News - April 2017: Additional Items
JHOP Web Exclusives published on April 14, 2017 in FDA News & Updates, Online Only
FDA News - April 2017
JHOP Web Exclusives published on April 1, 2017 in FDA News & Updates, Online Only
Last modified: September 2, 2015